Apyx Medical
APYX
64 hedge funds and large institutions have $134M invested in Apyx Medical in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 3 closing their positions.
428% more capital inflows, than outflows
Capital inflows: $6.18M | Capital outflows: $1.17M
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
35% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 17
5% more funds holding
Funds holding: 61 → 64 (+3)
2.08% more ownership
Funds ownership: 52.07% → 54.15% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$1.43M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$746K |
| 3 |
BlackRock
New York
|
+$640K |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
+$493K |
| 5 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
+$367K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PMG
ProVise Management Group
Clearwater,
Florida
|
-$306K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$156K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$126K |
| 4 |
State Street
Boston,
Massachusetts
|
-$122K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$116K |
APYX Hedge Fund Activity: Q4 2020 in Review
64 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q4 2020, worth a combined $134M — up 59% from $83.9M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new APYX positions and 3 closed out — a net gain of 3 holders — while 23 added to existing stakes and 17 trimmed.
The largest buyer was Kestra Advisory Services, opening a new position worth an estimated $1.43M. The largest seller was ProVise Management Group, cutting an estimated $306K.
- 64 institutional investors held Apyx Medical (APYX) as of Q4 2020, up from 61 in Q3 2020.
- Funds reported $134M of Apyx Medical stock for Q4 2020, up 59% quarter-over-quarter.
- 6 funds opened new Apyx Medical positions in Q4 2020 and 3 closed out, a net change of +3 holders.
- The largest Apyx Medical buyer in Q4 2020 was Kestra Advisory Services, an estimated $1.43M added.
- The largest Apyx Medical seller in Q4 2020 was ProVise Management Group, an estimated $306K sold.
Based on aggregated 13F filings for Q4 2020.